Compare CVS Health Corp (CVS) vs Stryker Corporation (SYK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CVS Health Corp vs Stryker Corporation — how do they compare? CVS Health Corp trades at $93.54 (market cap $119.58B), while Stryker Corporation trades at $346.62 (market cap $133.54B). The key difference: CVS Health Corp and Stryker Corporation are close in size by market cap, and CVS Health Corp pays the higher dividend (2.84%). Which is the better fit depends on your goals.
| CVS | SYK | |
|---|---|---|
Market Cap | $119.58B | $133.54B |
Sector | Health | Technology |
52-Week High | $110.60 | $394.34 |
52-Week Low | $65.51 | $282.58 |
Enterprise Value | $181.93B | $145.01B |
Dividend Yield | 2.84% | 1.01% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About CVS Health Corp
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →About Stryker Corporation
Stryker is a global leader in medical technology, specializing in Orthopaedics, MedSurg, and Neurotechnology. It is renowned for its highly decentralized business model, which empowers 22 specialized business units to drive innovation and category leadership. With its market-leading Mako SmartRobotics™ platform and a relentless M&A strategy, Stryker provides a comprehensive ecosystem of connected surgical tools, implants, and digital solutions that improve both clinical and financial outcomes for hospitals worldwide.
Read more on SYK →
